Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01170052
What this trial is testing

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Mantle Cell Lymphoma
Charite University, Berlin, Germany 20
Not applicableEnded earlyNCT02204904
What this trial is testing

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Who this might be right for
X-Linked Adrenoleukodystrophy (X-ALD)Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD)
Genetix Biotherapeutics Inc. 59
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Testing effectiveness (Phase 2)Ended earlyNCT04117477
What this trial is testing

Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati 46
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Early research (Phase 1)WithdrawnNCT05720988
What this trial is testing

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06362967
What this trial is testing

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

Who this might be right for
High Titers of Anti-HLA Antibody (MFI ≥5000)
Anhui Provincial Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07729995
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)+1 more
Luminary Therapeutics 94
Not applicableNot Yet RecruitingNCT07113730
What this trial is testing

The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes

Who this might be right for
Chronic Myelomonocytic Leukemia (CMML)Immune Reconstitution
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02841995
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Kadmon, a Sanofi Company 54
Large-scale testing (Phase 3)Study completedNCT00180869
What this trial is testing

Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients

Who this might be right for
CancerSurgery
Gustave Roussy, Cancer Campus, Grand Paris 150
Testing effectiveness (Phase 2)Ended earlyNCT01636388
What this trial is testing

Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkins Lymphoma
New York Medical College 2
Large-scale testing (Phase 3)Study completedNCT02997202
What this trial is testing

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 356
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Post-approval studies (Phase 4)Study completedNCT06811337
What this trial is testing

Marginal Bone Changes Around Dental Implant Placed With Open vs. Closed Sinus Elevation

Who this might be right for
Marginal Bone LevelsOpen Sinus ElevationClosed Sinus Elevation
Misr International University 52
Large-scale testing (Phase 3)Active Not RecruitingNCT05086939
What this trial is testing

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Who this might be right for
Knee Osteoarthritis
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 124
Not applicableUnknownNCT06143501
What this trial is testing

Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT

Who this might be right for
Graft Vs Host Disease
The First Affiliated Hospital of Soochow University 250
Testing effectiveness (Phase 2)UnknownNCT03540849
What this trial is testing

BV After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin Lymphoma
University Hospital, Caen 58
Early research (Phase 1)Study completedNCT03939026
What this trial is testing

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma
Allogene Therapeutics 50
Not applicableEnded earlyNCT01547143
What this trial is testing

Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Asan Medical Center 12
Next Page